Work

Peripheral F2‐isoprostanes and F4‐neuroprostanes are not increased in Alzheimer's disease

Year: 2002

Type: article

Study design: Observational Study

Source: Annals of Neurology

DOI: 10.1002/ana.10272

Authors: Thomas J. Montine, Joseph F. Quinn, Dejan Milatovic, Lisa C. Silbert, Theresa Dang, Stephanie Sanchez, Erin Terry, L. Jackson Roberts, Jeffrey A. Kaye, Jason D. Morrow

Institutions: Vanderbilt University Medical Center, Portland VA Medical Center

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Aging, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1509819248, ALZHEIMER'S DISEASE RESEARCH CENTER, G1954890623, G2377967270, G3066424320, G41007974, The Role of Bioactive Lipids in Inflammation and Cancer, G480672656, Oregon Alzheimer's Disease Center, LIPID PEROXIDATION AND APOE IN ALZHEIMERS DISEASE, Biochemistry and Pharmacology of D2/E2 Isoprostanes

OpenAlex ID: W2055021833

FWCI: 6.195

Cites: 22

Cited by: 156

Related to: 10